Home/Pipeline/ExoPTEN‑Glaucoma

ExoPTEN‑Glaucoma

Acute Glaucoma

PreclinicalActive

Key Facts

Indication

Acute Glaucoma

Phase

Preclinical

Status

Active

Company

NurExone Biologic

About NurExone Biologic

Exosome‑powered regenerative therapies for CNS injuries, leveraging a scalable nanodrug platform.

View full company profile

Therapeutic Areas

Central Nervous System Ophthalmology